Senior Director of Clinical Trials & Business Development
Michaele Linden-Johnson, MBA, FACHE, serves as the director of programs for the Medical Center of the Americas (MCA) Foundation. Prior to joining the MCA Foundation, Linden-Johnson served as the business Development manager at Denver Health, where she was responsible for managing key corporate accounts, driving business segments and expanding the reach of the company’s solution partner system and customer network.
Linden-Johnson comes to the MCA as a seasoned life science executive with a diverse business development background and long-standing record of achievements across the life science continuum. Linden-Johnson began her career serving in direct clinical and administrative roles for a neuropsychiatry department at the University of Illinois at Chicago. Upon obtaining her MBA, she conducted a comprehensive market analysis of Poudre Valley Health Systems and collaborated with multiple stakeholders to establish rural primary care clinics in northern Colorado. Subsequently, she was responsible for driving strategic partnerships, marketing strategy and managing key accounts for Cedarburg Hauser Pharmaceuticals. She helped increase their revenue by over 400 percent in four years, making them a prime target for acquisition in March 2009. Following the acquisition, she and a former Cedarburg Hauser colleague co-owned Boulder Biopharmaceuticals, LLC, a contract service company targeting the pharmaceutical and healthcare industries. She was responsible for cultivating strategic business relationships with industry, academic and C-level contacts to grow the startup, while also advancing STTR/SBIR funding opportunities and compelling solutions to address stakeholder needs.
A Fellow of the American College of Healthcare Executives (FACHE), Linden-Johnson offers extensive experience in strategic planning, strategic partnerships, merger and acquisition, account management and sales and marketing of contract services targeting the life science industry using a consultative solution selling approach.
Linden-Johnson holds a B.A. in molecular, cellular and developmental biology from the University of Colorado, a master’s degree in social work from the University of Chicago, and an MBA from the University of Colorado. She has served on a number of boards, including the Colorado Association for Healthcare Executives (CAHE), the Institutional Review Board (IRB) for Poudre Valley Health Systems and the Alzheimer’s Grant Review committee for the State of Illinois.
Her areas of interest include: Biomedical Innovation, Novel Diagnostics & Therapeutics, Clinical Trial Research, Telehealth, mHealth, Behavioral Health and Population Health